Drug:
Reaction: DYSPNOEA
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940061 |
US |
2 | |
Dyspnoea, Hernia, |
||||
ADALIMUMAB-ATTO, |
||||
| 2 | 26940118 |
US |
72 | 2 |
Dyspnoea, |
||||
PANCRELIPASE, |
||||
| 3 | 26940235 |
US |
2 | |
Irregular sleep phase, Dyspnoea, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, CETIRIZINE HCL, CETIRIZINE, IRON, FUROSEMIDE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, LORAZEPAM, LOTEPREDNOL ETABONATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE, ROFLUMILAST, ROSUVASTATIN CALCIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, LEVOTHYROXINE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, VITAMIN C, |
||||
| 4 | 26940290 |
US |
2 | |
Dyspnoea, Nausea, |
||||
PEGLOTICASE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 5 | 26940313 |
US |
66 | 2 |
Dry mouth, Somnolence, Illness, Abdominal discomfort, Headache, Nausea, Dyspnoea, Fatigue, Product administered at inappropriate site, Product dose omission issue, |
||||
ABALOPARATIDE, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CETIRIZINE HYDROCHLORIDE, SPIRONOLACTONE, NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%, |
||||
| 6 | 26940346 |
US |
2 | |
Back pain, Dyspnoea, Frustration tolerance decreased, Drug ineffective, |
||||
ABALOPARATIDE, |
||||
| 7 | 26940367 |
GB |
56 | 1 |
Dyspnoea, |
||||
| 8 | 26940376 |
US |
71 | 1 |
Feeling abnormal, Cardiac disorder, Dyspnoea, |
||||
| 9 | 26940409 |
GB |
35 | 2 |
Flushing, Generalised oedema, Cold sweat, Headache, Swelling face, Dyspnoea, Dizziness, Vomiting, Peripheral swelling, Palmar erythema, Rash, |
||||
USTEKINUMAB, LANSOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SCOPOLAMINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MORPHINE SULFATE, |
||||
| 10 | 26940463 |
US |
70 | 2 |
Impaired gastric emptying, Abdominal pain upper, Decreased appetite, Diarrhoea, Pruritus, Dyspnoea, |
||||
AGALSIDASE BETA, |
||||
| 11 | 26940518 |
US |
62 | 2 |
Hyperventilation, Head discomfort, Dyspnoea, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 12 | 26940631 |
US |
2 | |
Dysarthria, Gastrointestinal disorder, Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 13 | 26940647 |
US |
85 | 2 |
Hypoxia, Ileus, Dyspnoea, Nausea, |
||||
NERANDOMILAST, NINTEDANIB, |
||||
| 14 | 26940680 |
US |
64 | 2 |
Vomiting, Palpitations, Tachycardia, Dyspnoea, Asthenia, Constipation, Blood calcium increased, |
||||
ABALOPARATIDE, MAGNESIUM, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CLONAZEPAM, GABAPENTIN, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, TIZANIDINE, |
||||
| 15 | 26940704 |
US |
2 | |
Tremor, Discomfort, Chest pain, Blood pressure abnormal, Heart rate increased, Injection site swelling, Injection site bruising, Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 16 | 26940763 |
US |
2 | |
Hernia repair, Scar, Fear of injection, Allergy to chemicals, Otorrhoea, Visual impairment, Nasal congestion, Sinusitis, Hernia, Dyspepsia, Eczema, Dyspnoea, Dizziness, Blood pressure increased, Nausea, Palpitations, Blood calcium increased, Headache, Arthralgia, Incorrect dose administered, Product distribution issue, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, CALCIUM, |
||||
| 17 | 26940822 |
US |
66 | 1 |
Dyspnoea, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 18 | 26940888 |
US |
25 | 2 |
Oedema peripheral, Premature delivery, Acute kidney injury, Caesarean section, Blood loss anaemia, Ileus paralytic, Hydroureter, Hydronephrosis, Hysterectomy, Laparotomy, Salpingectomy, Dyspnoea, Lymphoedema, Vomiting, Exposure during pregnancy, Drug ineffective, |
||||
OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, INDOMETHACIN, MORPHINE, MAGNESIUM, |
||||
| 19 | 26940891 |
US |
2 | |
Dyspnoea, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, FAMOTIDINE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), RIFAXIMIN, MAGNESIUM, AIRBORNE, FUROSEMIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, TADALAFIL, ALBUTEROL SULFATE, ROSUVASTATIN, ALPRAZOLAM, OXYGEN, 0XYGEN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, COLESTIPOL HYDROCHLORIDE, DIGOXIN, ONDANSETRON HYDROCHLORIDE, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, |
||||
| 20 | 26941060 |
US |
2 | |
Drug intolerance, Gait disturbance, Dyspnoea, Pain in extremity, Arthralgia, Fatigue, Bone pain, Headache, Product use issue, Off label use, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 21 | 26941113 |
CN |
72 | 1 |
Dyspnoea, Palpitations, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 22 | 26941130 |
US |
69 | 2 |
Feeling jittery, Fungal skin infection, Dyspnoea, Heart rate increased, Fatigue, Blood calcium increased, Palpitations, Off label use, Drug dose omission by device, Liquid product physical issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 23 | 26941175 |
US |
2 | |
Scoliosis, Fall, Dyspnoea, Device issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 24 | 26941217 |
GB |
21 | 2 |
Lower respiratory tract infection, Pyrexia, Dyspnoea, Nausea, SARS-CoV-2 test positive, Nasopharyngitis, Aphasia, Influenza like illness, Nasal congestion, Cough, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 25 | 26941289 |
US |
2 | |
Dyspnoea, Cough, |
||||
DUPILUMAB, |
||||
| 26 | 26941524 |
KH |
2 | |
Cholelithiasis, Chronic myeloid leukaemia, Malignant neoplasm progression, Vaginal haemorrhage, Uterine haemorrhage, Haematochezia, Hypothyroidism, Malaise, Diabetes mellitus, Loose tooth, Blood creatinine decreased, Varicose vein, Drug intolerance, Cardiac disorder, Crying, Transferrin saturation decreased, Blood cholesterol increased, Microalbuminuria, White blood cell count increased, Prothrombin time shortened, Blood lactate dehydrogenase abnormal, Lymphocyte count abnormal, Antinuclear antibody positive, Blood triglycerides increased, Product dose omission issue, Iron deficiency anaemia, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Manganese increased, Neutrophil count increased, Mean cell haemoglobin concentration abnormal, Neck pain, Back pain, Pallor, Ocular hyperaemia, Pain, Peripheral swelling, Oedema peripheral, Normochromic normocytic anaemia, Hepatomegaly, Dyslipidaemia, Hyperglycaemia, Hepatic steatosis, Arthralgia, Pain in extremity, Chest pain, Haemoglobin decreased, Anaemia, Dyspnoea, Anxiety, Tachycardia, White blood cell count abnormal, Cough, Blood pressure increased, Blood iron decreased, Cytogenetic analysis abnormal, Hypertension, Depression, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, CALCIUM, |
||||
| 27 | 26941591 |
US |
71 | 2 |
Myalgia, Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 28 | 26941601 |
GB |
||
Blindness, Hypertension, Dyspnoea, Throat irritation, Neck pain, |
||||
USTEKINUMAB, |
||||
| 29 | 26941604 |
US |
61 | 2 |
Vision blurred, Ear discomfort, Dyspnoea, Chest pain, Headache, Arthralgia, Pain in extremity, Pain, Dyspnoea exertional, Pollakiuria, Pain in jaw, Migraine, |
||||
SELEXIPAG, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, BUMETANIDE, |
||||
| 30 | 26941672 |
US |
63 | 2 |
Emotional disorder, Presyncope, Dyspnoea, Asthenia, Diarrhoea, Fatigue, Headache, Decreased appetite, Perioral dermatitis, Rash, |
||||
VANDETANIB, VENLAFAXINE HYDROCHLORIDE, |
||||
| 31 | 26941754 |
US |
69 | 2 |
Dyspnoea, Incorrect dose administered, |
||||
ABALOPARATIDE, |
||||
| 32 | 26941830 |
US |
72 | 2 |
Vision blurred, Fatigue, Arthralgia, Headache, Dyspnoea, Dizziness, Heart rate increased, Product dose omission in error, |
||||
ABALOPARATIDE, |
||||
| 33 | 26941931 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
ERENUMAB-AOOE, ETANERCEPT, ETANERCEPT, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, |
||||
| 34 | 26942002 |
IN |
69 | 1 |
Off label use, Lower respiratory tract infection, Dyspnoea, |
||||
FARICIMAB, FARICIMAB, |
||||
| 35 | 26942144 |
EU |
81 | 1 |
Malaise, Erythema, Hypertension, Dyspnoea, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, METHYLPREDNISOLONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LEUPROLIDE ACETATE, DAROLUTAMIDE, |
||||
| 36 | 26942151 |
US |
18 | 1 |
Haematemesis, Chest pain, Dyspnoea, Nausea, Dizziness, Headache, Abdominal pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 37 | 26942229 |
US |
2 | |
Palpitations, Dyspnoea, Seasonal allergy, Treatment noncompliance, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ERGOCALCIFEROL, RIOCIGUAT, VALSARTAN, VALSARTAN ORAL, ATORVASTATIN CALCIUM, CLONAZEPAM, FUROSEMIDE, ALBUTEROL SULFATE, SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE, OXYGEN, 0XYGEN, DIPHENHYDRAMINE HYDROCHLORIDE, LETROZOLE, LETROZOLE TABLETS, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, AMBRISENTAN, AMBRISENTAN, |
||||
| 38 | 26942274 |
EU |
70 | 2 |
Abdominal discomfort, Palpitations, Lymphocyte count increased, White blood cell count increased, Neutrophil count increased, Dyspnoea, |
||||
| 39 | 26942441 |
US |
69 | 2 |
Asthma, Dyspnoea, Cough, Dyspnoea, Incorrect dose administered, |
||||
DUPILUMAB, TEZEPELUMAB-EKKO, |
||||
| 40 | 26942453 |
US |
58 | 1 |
Fatigue, Presyncope, Hypotension, Dyspnoea, Respiratory tract infection, |
||||
DUPILUMAB, |
||||
| 41 | 26942475 |
EU |
75 | 2 |
Anal haemorrhage, Dyspnoea, Asthenia, Haemoglobin decreased, |
||||
CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, KETOPROFEN, |
||||
| 42 | 26942611 |
CA |
74 | 1 |
Fatigue, Full blood count abnormal, Alanine aminotransferase abnormal, Dyspnoea, Hospitalisation, Asthma, Bronchiectasis, Cough, Therapeutic product effect incomplete, Rhinorrhoea, Sputum discoloured, Blood alkaline phosphatase abnormal, Chest pain, Lung opacity, |
||||
ITRACONAZOLE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, MEPOLIZUMAB, MEPOLIZUMAB, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LANSOPRAZOLE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, DEXLANSOPRAZOLE, LANSOPRAZOLE, PAROXETINE HYDROCHLORIDE, ITRACONAZOLE, BUPROPION HYDROCHLORIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, OMALIZUMAB, |
||||
| 43 | 26942976 |
39 | 2 | |
Swollen tongue, Pharyngeal swelling, Loss of consciousness, Lip swelling, Dyspnoea, |
||||
| 44 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 45 | 26943235 |
55 | 1 | |
Bradycardia, Hypotension, Pyrexia, Lung infiltration, Respiratory failure, Shock, Pulmonary embolism, Dyspnoea, Syncope, Anaemia, Asthenia, Cardio-respiratory arrest, Aspiration, |
||||
DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 46 | 26943247 |
US |
61 | 2 |
Neuralgia, Hypoaesthesia, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 47 | 26943331 |
GB |
39 | 2 |
Nausea, Livedo reticularis, Dizziness, Vomiting, Dyspnoea, Fatigue, Gastritis, Migraine, |
||||
LANSOPRAZOLE, |
||||
| 48 | 26943539 |
AU |
68 | 1 |
Hypotension, Feeling hot, Hyperhidrosis, Dry throat, Facial discomfort, Adverse drug reaction, Headache, Dysphagia, Hypoaesthesia, Fatigue, Throat tightness, Flushing, Head discomfort, Eyelid ptosis, Dizziness, Hyperhidrosis, Dyspnoea, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, NASAL, SODIUM CHLORIDE, SALINE, SALINE NASAL SPRAY, (SALINE), |
||||
| 49 | 26943542 |
CA |
48 | |
Dyspnoea, Respiratory disorder, Condition aggravated, Diarrhoea, Therapy cessation, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MOMETASONE, MONTELUKAST, |
||||
| 50 | 26943576 |
US |
24 | 1 |
Feeling abnormal, Dyspnoea, Headache, |
||||
AVALGLUCOSIDASE ALFA-NGPT, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 51 | 26943589 |
US |
73 | 2 |
Aspiration, Catatonia, Dysphagia, Dyspnoea, Oxygen saturation decreased, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 52 | 26943689 |
US |
37 | 1 |
Death, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 53 | 26943707 |
EU |
||
Clostridium difficile colitis, Dyspnoea, Pain, Condition aggravated, Inflammatory marker increased, Anaemia, Oedema peripheral, Pleural effusion, Respiratory failure, Serratia infection, General physical health deterioration, Swelling, Clostridium difficile infection, Laboratory test abnormal, Drug ineffective, |
||||
PANTOPRAZOLE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, PREGABALIN, PREGABALIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, RAMIPRIL, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, CYCLOSPORINE, CALCIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CALCIUM GLUCONATE, IRON SUCROSE, TORSEMIDE, ERYTHROPOIETIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, |
||||
| 54 | 26943717 |
CN |
67 | 2 |
Cold sweat, Nausea, Dyspnoea, Vomiting, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 55 | 26943803 |
US |
2 | |
Diarrhoea haemorrhagic, Dyspnoea, Pallor, Vomiting, Dizziness, Skin discolouration, |
||||
TIRZEPATIDE, |
||||
| 56 | 26943809 |
US |
48 | 2 |
Haematemesis, Headache, Feeling abnormal, Cardiac flutter, Anxiety, Choking, Dyspnoea, Abdominal pain, Sleep disorder, Product dose omission issue, |
||||
TIRZEPATIDE, |
||||
| 57 | 26943983 |
US |
2 | |
Dyspnoea, Dental discomfort, Heart rate irregular, Adverse drug reaction, |
||||
BRENSOCATIB, LOSARTAN, FAMOTIDINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MONTELUKAST SODIUM, DILTIAZEM HYDROCHLORIDE, |
||||
| 58 | 26943990 |
US |
70 | 1 |
Asthenia, Fatigue, Dyspnoea, |
||||
RISDIPLAM, |
||||
| 59 | 26943998 |
EU |
53 | 2 |
Angioedema, Erythema, Pruritus, Dyspnoea, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 60 | 26944012 |
EU |
51 | 2 |
Fatigue, Peripheral swelling, Dyspnoea, Hypersensitivity, Pain in extremity, Diarrhoea, Hypoaesthesia, Paraesthesia, Headache, |
||||
DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, DOXAZOSIN, DOXAZOSIN MESYLATE, |
||||
| 61 | 26944031 |
US |
69 | 1 |
Headache, Flushing, Dyspnoea, Hyperhidrosis, |
||||
SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, CLOPIDOGREL, LOSARTAN, SPIRONOLACTONE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 62 | 26944173 |
US |
75 | 2 |
Influenza, Condition aggravated, Dyspnoea, Dysphagia, Lung disorder, Feeding disorder, Product use in unapproved indication, |
||||
DUPILUMAB, CARVEDILOL, EPINEPHRINE, ADRENALINUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, EZETIMIBE, FAMOTIDINE, FUROSEMIDE, MAGNESIUM, MONTELUKAST, BEMPEDOIC ACID, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VITAMIN C, VITAMIN E, |
||||
| 63 | 26944181 |
US |
69 | 2 |
Productive cough, Dyspnoea, Loss of personal independence in daily activities, |
||||
DUPILUMAB, |
||||
| 64 | 26944200 |
US |
76 | 2 |
Dyspnoea, |
||||
LENALIDOMIDE, |
||||
| 65 | 26944206 |
VN |
50 | 2 |
Bone pain, Dyspnoea, Metastases to liver, Gastrointestinal disorder, Gastritis, Enteritis, Pyrexia, Cough, |
||||
CERITINIB, CERITINIB, CERITINIB, ZOLEDRONIC ACID, |
||||
| 66 | 26944321 |
RU |
||
Arrhythmia, Dyspnoea, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 67 | 26944426 |
|||
Dyspnoea, Fear of death, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 68 | 26944492 |
US |
2 | |
Somnolence, Palpitations, Dyspnoea, Irritability, Insomnia, Migraine, Chest discomfort, Heart rate increased, Dizziness, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 69 | 26944560 |
EU |
64 | 2 |
Dyspnoea, Interstitial lung disease, Acute respiratory distress syndrome, Fibrosis, |
||||
BLEOMYCIN, BLEOMYCIN SULFATE, DACARBAZINE, DOXORUBICIN, |
||||
| 70 | 26944588 |
AU |
70 | 1 |
Aortic stenosis, Lower respiratory tract infection, Dyspnoea, Asthma, |
||||
DUPILUMAB, CLARITHROMYCIN, DENOSUMAB, PANTOPRAZOLE, MOMETASONE FUROATE, |
||||
| 71 | 26944732 |
US |
2 | |
Muscular weakness, Dyspnoea, Muscle spasms, Headache, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 72 | 26944905 |
US |
1 | |
Pollakiuria, Dyspnoea, Product use in unapproved indication, |
||||
SPARSENTAN, |
||||
| 73 | 26944918 |
GB |
1 | |
Abscess oral, Neuropathy peripheral, Protein urine present, Glucose urine present, Fatigue, Dyspnoea, Diarrhoea, |
||||
IRINOTECAN HYDROCHLORIDE, BEVACIZUMAB, CAPECITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 74 | 26944996 |
US |
62 | 2 |
Dyspnoea, Nasopharyngitis, Dry skin, Skin exfoliation, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 75 | 26945058 |
55 | 2 | |
Loss of consciousness, Sleep apnoea syndrome, Fall, Middle insomnia, Musculoskeletal stiffness, Balance disorder, Dry throat, Asthenia, Illness, Oropharyngeal pain, Nasal congestion, Somnolence, Nocturia, Memory impairment, Disorientation, Somnambulism, Contusion, Insomnia, Fatigue, Tremor, Dyspnoea, |
||||
ARMODAFINIL, ARMODAFINIL, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, |
||||
| 76 | 26945084 |
US |
2 | |
Sensation of blood flow, Dyspnoea, Palpitations, Insomnia, Muscle spasms, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 77 | 26945121 |
US |
2 | |
Joint swelling, Vision blurred, Hot flush, Dyspnoea, Dizziness, Palpitations, Fatigue, Asthenia, Bone pain, Diarrhoea, Abdominal distension, |
||||
ABALOPARATIDE, ADALIMUMAB, |
||||
| 78 | 26945180 |
CN |
28 | 2 |
Dermatitis allergic, Rash pruritic, Headache, Chest discomfort, Dyspnoea, Asthenia, Discomfort, |
||||
AMOXICILLIN, |
||||
| 79 | 26945215 |
US |
77 | 2 |
Visual impairment, Chest pain, Stress, Nausea, Headache, Dyspnoea, Blood pressure increased, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, NEBIVOLOL HYDROCHLORIDE, |
||||
| 80 | 26945237 |
US |
2 | |
Night sweats, Areflexia, COVID-19, Negative thoughts, Decreased appetite, Bone pain, Fatigue, Nausea, Dyspnoea, Product dose omission in error, Product prescribing issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, BUPRENORPHINE, BUSPIRONE HYDROCHLORIDE, LATANOPROST, PANTOPRAZOLE, PAROXETINE HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 81 | 26945242 |
US |
2 | |
Myalgia, Dry skin, Urinary tract infection, Blood pressure increased, Dyspnoea, Vomiting, Palpitations, Bone pain, Nausea, Heart rate increased, Abdominal distension, Insomnia, Pruritus, Fatigue, Arthralgia, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHOCARBAMOL, FEXOFENADINE HYDROCHLORIDE, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80, CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CALCIUM CARBONATE, ERGOCALCIFEROL, CARVEDILOL, FISH OIL, CARVEDILOL, CARBOXYMETHYLCELLULOSE SODIUM, METHIMAZOLE, FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE, FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CALCIUM CARBONATE, ANTACID, PYRITHIONE ZINC, CETIRIZINE HYDROCHLORIDE, |
||||
| 82 | 26945243 |
US |
2 | |
Urticaria, Dyspnoea, |
||||
| 83 | 26945475 |
US |
52 | 1 |
Anaphylactic reaction, Dyspnoea, Sleep disorder due to a general medical condition, Incorrect dose administered, |
||||
DUPILUMAB, BENRALIZUMAB, PREDNISONE, CETIRIZINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
| 84 | 26945535 |
US |
78 | 2 |
Hypotension, Headache, Arthralgia, Nausea, Dizziness, Abdominal pain, Dyspnoea, Tachycardia, |
||||
ABALOPARATIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 85 | 26945614 |
US |
60 | 2 |
Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 86 | 26945674 |
US |
2 | |
Off label use, Dyspnoea, |
||||
OMALIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, MONTELUKAST SODIUM, MONTELUKAST, CLOPIDOGREL, ENALAPRIL MALEATE, ENALAPRIL, |
||||
| 87 | 26945712 |
CA |
62 | 2 |
Loss of personal independence in daily activities, Therapeutic product effect incomplete, Drug dependence, Dyspnoea, Lung adenocarcinoma stage IV, Steroid dependence, Chest discomfort, Malaise, Sleep disorder due to a general medical condition, Illness, Exercise tolerance decreased, Metastases to central nervous system, Pneumothorax, Wheezing, Chronic obstructive pulmonary disease, Bronchitis, Bone pain, Seizure, Heart rate increased, Asthma, Full blood count abnormal, Joint swelling, Gait disturbance, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, ERGOCALCIFEROL, ERGOCALCIFEROL, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, MEPOLIZUMAB, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 88 | 26945884 |
US |
63 | 2 |
Injection site irritation, Bone disorder, Muscle discomfort, Nasopharyngitis, Feeling abnormal, Injection site erythema, Injection site bruising, Back pain, Dyspnoea, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 89 | 26945943 |
US |
53 | 1 |
Pruritus, Anxiety, Dyspnoea, Night sweats, Feeling abnormal, Nightmare, |
||||
SPARSENTAN, |
||||
| 90 | 26946045 |
US |
66 | 1 |
Gastrointestinal tube insertion, Frequent bowel movements, Dyspnoea, Tracheal disorder, Abdominal discomfort, Abdominal pain upper, |
||||
PANCRELIPASE, |
||||
| 91 | 26946059 |
US |
2 | |
Dizziness, Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 92 | 26946060 |
US |
||
Dyspnoea, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 93 | 26946085 |
US |
66 | 2 |
Hypoglycaemia, Visual impairment, Muscular weakness, Muscle contractions involuntary, Migraine, Memory impairment, Eyelid ptosis, Dyspnoea, Neck pain, Headache, Heart rate increased, Injection site pain, Injection site bruising, Bone pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, CALCIUM CARBONATE, MUPIROCIN, MUPIROCIN CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FEXOFENADINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ONABOTULINUMTOXINA, ONDANSETRON HYDROCHLORIDE, MELATONIN, ZOLPIDEM TARTRATE, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, CARISOPRODOL, GABAPENTIN, FAMOTIDINE, CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 94 | 26946159 |
US |
2 | |
Chest discomfort, Dyspepsia, Dyspnoea, Injection site erythema, |
||||
ABALOPARATIDE, |
||||
| 95 | 26946213 |
US |
2 | |
Dyspnoea, Fatigue, Dizziness, Injection site reaction, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, SIMVASTATIN, |
||||
| 96 | 26946321 |
CA |
40 | 2 |
Back injury, Fall, Arthralgia, Liver function test increased, Muscle spasms, Bursitis, Dyspepsia, Nail disorder, Vomiting, Mobility decreased, Osteoarthritis, C-reactive protein increased, Confusional state, Blood cholesterol increased, Injury, Swelling, Drug hypersensitivity, Diarrhoea, Dyspnoea, Abdominal discomfort, Grip strength decreased, Hand deformity, Headache, Arthropathy, Abdominal distension, Malaise, Folliculitis, Onychomadesis, Memory impairment, Hypertension, Gastrooesophageal reflux disease, Hypersensitivity, Normal newborn, Nausea, Onychomycosis, Peripheral swelling, Glossodynia, Maternal exposure timing unspecified, Maternal exposure during pregnancy, Exposure during pregnancy, Product label confusion, |
||||
ETANERCEPT, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, CAFFEINE, CAFFEINE, CAFFEINE, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 97 | 26946424 |
US |
53 | 2 |
Head discomfort, Back pain, Headache, Dyspnoea, Insomnia, Fatigue, Palpitations, |
||||
ABALOPARATIDE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, VITAMIN C, FISH OIL, |
||||
| 98 | 26946468 |
US |
1 | |
Presyncope, Condition aggravated, Injection site bruising, Dizziness, Heart rate increased, Insomnia, Dyspnoea, |
||||
ABALOPARATIDE, ABALOPARATIDE, CLONIDINE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE, FUROSEMIDE, LISINOPRIL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, FISH OIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CYANOCOBALAMIN, ERGOCALCIFEROL, |
||||
| 99 | 26946486 |
US |
79 | 2 |
Stress, Fatigue, Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 100 | 26946638 |
US |
2 | |
Oxygen saturation decreased, Anxiety, Dyspnoea, Headache, Accidental overdose, |
||||
ABALOPARATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30